CPRX logo

Catalyst Pharmaceuticals (CPRX) Net income

annual net income:

$163.89M+$92.48M(+129.50%)
December 31, 2024

Summary

  • As of today (July 1, 2025), CPRX annual net profit is $163.89 million, with the most recent change of +$92.48 million (+129.50%) on December 31, 2024.
  • During the last 3 years, CPRX annual net income has risen by +$124.41 million (+315.10%).
  • CPRX annual net income is now at all-time high.

Performance

CPRX Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCPRXincome statement metrics

quarterly net income:

$56.74M+$801.00K(+1.43%)
March 31, 2025

Summary

  • As of today (July 1, 2025), CPRX quarterly net profit is $56.74 million, with the most recent change of +$801.00 thousand (+1.43%) on March 31, 2025.
  • Over the past year, CPRX quarterly net income has increased by +$33.46 million (+143.77%).
  • CPRX quarterly net income is now at all-time high.

Performance

CPRX quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCPRXincome statement metrics

TTM net income:

$197.35M+$33.46M(+20.42%)
March 31, 2025

Summary

  • As of today (July 1, 2025), CPRX TTM net profit is $197.35 million, with the most recent change of +$33.46 million (+20.42%) on March 31, 2025.
  • Over the past year, CPRX TTM net income has increased by +$132.23 million (+203.07%).
  • CPRX TTM net income is now at all-time high.

Performance

CPRX TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCPRXincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

CPRX Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+129.5%+143.8%+203.1%
3 y3 years+315.1%+328.5%+338.0%
5 y5 years+414.2%+444.2%+372.5%

CPRX Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+315.1%at high+284.4%at high+262.1%
5 y5-yearat high+414.2%at high+284.4%at high+399.9%
alltimeall timeat high+582.0%at high+284.4%at high+680.4%

CPRX Net income History

DateAnnualQuarterlyTTM
Mar 2025
-
$56.74M(+1.4%)
$197.35M(+20.4%)
Dec 2024
$163.89M(+129.5%)
$55.94M(+27.5%)
$163.89M(+14.8%)
Sep 2024
-
$43.88M(+7.6%)
$142.80M(+109.5%)
Jun 2024
-
$40.79M(+75.3%)
$68.15M(+4.7%)
Mar 2024
-
$23.27M(-33.2%)
$65.12M(-8.8%)
Dec 2023
$71.41M(-14.0%)
$34.84M(-213.3%)
$71.41M(+15.1%)
Sep 2023
-
-$30.76M(-181.5%)
$62.04M(-46.3%)
Jun 2023
-
$37.76M(+27.7%)
$115.55M(+16.2%)
Mar 2023
-
$29.57M(+16.1%)
$99.41M(+19.7%)
Dec 2022
$83.08M(+110.4%)
$25.47M(+12.0%)
$83.08M(+24.2%)
Sep 2022
-
$22.75M(+5.2%)
$66.92M(+22.8%)
Jun 2022
-
$21.62M(+63.3%)
$54.50M(+20.9%)
Mar 2022
-
$13.24M(+42.2%)
$45.06M(+14.1%)
Dec 2021
$39.48M(-47.3%)
$9.31M(-9.9%)
$39.48M(-5.1%)
Sep 2021
-
$10.33M(-15.2%)
$41.61M(-44.2%)
Jun 2021
-
$12.18M(+59.0%)
$74.62M(+3.3%)
Mar 2021
-
$7.66M(-33.0%)
$72.22M(-3.7%)
Dec 2020
$74.98M(+135.2%)
$11.44M(-73.6%)
$74.98M(+4.9%)
Sep 2020
-
$43.34M(+343.1%)
$71.48M(+71.1%)
Jun 2020
-
$9.78M(-6.2%)
$41.77M(-2.7%)
Mar 2020
-
$10.43M(+31.5%)
$42.95M(+34.7%)
Dec 2019
$31.88M(-193.7%)
$7.93M(-41.8%)
$31.88M(+237.4%)
Sep 2019
-
$13.63M(+24.4%)
$9.45M(-178.6%)
Jun 2019
-
$10.96M(-1800.5%)
-$12.02M(-58.5%)
Mar 2019
-
-$644.50K(-95.6%)
-$28.95M(-14.9%)
Dec 2018
-$34.00M(+84.7%)
-$14.50M(+85.0%)
-$34.00M(+36.6%)
Sep 2018
-
-$7.84M(+31.4%)
-$24.89M(+17.2%)
Jun 2018
-
-$5.97M(+4.7%)
-$21.23M(+10.9%)
Mar 2018
-
-$5.70M(+5.8%)
-$19.15M(+4.0%)
Dec 2017
-$18.41M(+1.9%)
-$5.39M(+29.0%)
-$18.41M(+7.1%)
Sep 2017
-
-$4.18M(+7.7%)
-$17.19M(+1.3%)
Jun 2017
-
-$3.88M(-21.9%)
-$16.96M(-3.9%)
Mar 2017
-
-$4.97M(+19.3%)
-$17.65M(-2.3%)
Dec 2016
-$18.07M(-10.7%)
-$4.16M(+5.3%)
-$18.07M(-8.4%)
Sep 2016
-
-$3.95M(-13.5%)
-$19.72M(-2.4%)
Jun 2016
-
-$4.57M(-15.2%)
-$20.22M(+0.1%)
Mar 2016
-
-$5.39M(-7.4%)
-$20.21M(-0.1%)
Dec 2015
-$20.23M(+30.5%)
-$5.82M(+30.7%)
-$20.23M(+13.0%)
Sep 2015
-
-$4.45M(-2.4%)
-$17.91M(-3.0%)
Jun 2015
-
-$4.56M(-15.7%)
-$18.47M(+8.0%)
Mar 2015
-
-$5.41M(+55.0%)
-$17.11M(+10.3%)
Dec 2014
-$15.51M
-$3.49M(-30.3%)
-$15.51M(+16.0%)
Sep 2014
-
-$5.01M(+56.7%)
-$13.37M(-6.3%)
DateAnnualQuarterlyTTM
Jun 2014
-
-$3.20M(-16.1%)
-$14.28M(+0.4%)
Mar 2014
-
-$3.81M(+181.3%)
-$14.22M(+17.0%)
Dec 2013
-$12.15M(+198.2%)
-$1.35M(-77.1%)
-$12.15M(+11.8%)
Sep 2013
-
-$5.91M(+88.1%)
-$10.88M(+43.4%)
Jun 2013
-
-$3.14M(+80.2%)
-$7.59M(+60.3%)
Mar 2013
-
-$1.74M(+2177.2%)
-$4.73M(+16.1%)
Dec 2012
-$4.08M(-36.2%)
-$76.60K(-97.1%)
-$4.08M(-35.8%)
Sep 2012
-
-$2.62M(+806.8%)
-$6.35M(+30.7%)
Jun 2012
-
-$289.10K(-73.5%)
-$4.86M(-18.5%)
Mar 2012
-
-$1.09M(-53.7%)
-$5.96M(-6.7%)
Dec 2011
-$6.39M(+59.5%)
-$2.35M(+108.5%)
-$6.39M(+34.0%)
Sep 2011
-
-$1.13M(-19.1%)
-$4.77M(+4.9%)
Jun 2011
-
-$1.39M(-8.1%)
-$4.54M(+1.5%)
Mar 2011
-
-$1.52M(+108.2%)
-$4.48M(+11.8%)
Dec 2010
-$4.01M(-44.7%)
-$728.80K(-19.4%)
-$4.01M(-9.8%)
Sep 2010
-
-$904.00K(-32.0%)
-$4.44M(-7.9%)
Jun 2010
-
-$1.33M(+27.1%)
-$4.82M(-8.2%)
Mar 2010
-
-$1.04M(-10.1%)
-$5.26M(-27.4%)
Dec 2009
-$7.24M(-31.5%)
-$1.16M(-9.7%)
-$7.24M(-26.3%)
Sep 2009
-
-$1.29M(-27.0%)
-$9.83M(-13.8%)
Jun 2009
-
-$1.76M(-41.9%)
-$11.40M(-5.1%)
Mar 2009
-
-$3.03M(-19.1%)
-$12.01M(+13.7%)
Dec 2008
-$10.56M(+155.2%)
-$3.75M(+31.2%)
-$10.56M(+36.1%)
Sep 2008
-
-$2.86M(+20.1%)
-$7.76M(+37.6%)
Jun 2008
-
-$2.38M(+50.1%)
-$5.64M(+26.2%)
Mar 2008
-
-$1.58M(+67.6%)
-$4.47M(+8.0%)
Dec 2007
-$4.14M(+51.7%)
-$944.90K(+28.7%)
-$4.14M(+5.2%)
Sep 2007
-
-$734.30K(-39.2%)
-$3.94M(-13.0%)
Jun 2007
-
-$1.21M(-3.5%)
-$4.52M(+23.3%)
Mar 2007
-
-$1.25M(+68.9%)
-$3.67M(+33.4%)
Dec 2006
-$2.73M(+51.2%)
-$741.20K(-43.9%)
-$2.75M(-17.4%)
Sep 2006
-
-$1.32M(+273.3%)
-$3.33M(+48.0%)
Jun 2006
-
-$354.00K(+6.2%)
-$2.25M(-12.0%)
Mar 2006
-
-$333.40K(-74.8%)
-$2.56M(-11.3%)
Dec 2005
-$1.81M(+234.5%)
-$1.32M(+446.4%)
-$2.89M(+69.9%)
Sep 2005
-
-$241.90K(-63.4%)
-$1.70M(+6.7%)
Jun 2005
-
-$660.80K(0.0%)
-$1.59M(+49.3%)
Mar 2005
-
-$660.80K(+389.5%)
-$1.07M(+97.4%)
Dec 2004
-$539.80K(+25.9%)
-$135.00K(0.0%)
-$540.00K(+33.3%)
Sep 2004
-
-$135.00K(0.0%)
-$405.00K(+50.0%)
Jun 2004
-
-$135.00K(0.0%)
-$270.00K(+100.0%)
Mar 2004
-
-$135.00K
-$135.00K
Dec 2003
-$428.60K(+67.5%)
-
-
Dec 2002
-$255.90K
-
-

FAQ

  • What is Catalyst Pharmaceuticals annual net profit?
  • What is the all time high annual net income for Catalyst Pharmaceuticals?
  • What is Catalyst Pharmaceuticals annual net income year-on-year change?
  • What is Catalyst Pharmaceuticals quarterly net profit?
  • What is the all time high quarterly net income for Catalyst Pharmaceuticals?
  • What is Catalyst Pharmaceuticals quarterly net income year-on-year change?
  • What is Catalyst Pharmaceuticals TTM net profit?
  • What is the all time high TTM net income for Catalyst Pharmaceuticals?
  • What is Catalyst Pharmaceuticals TTM net income year-on-year change?

What is Catalyst Pharmaceuticals annual net profit?

The current annual net income of CPRX is $163.89M

What is the all time high annual net income for Catalyst Pharmaceuticals?

Catalyst Pharmaceuticals all-time high annual net profit is $163.89M

What is Catalyst Pharmaceuticals annual net income year-on-year change?

Over the past year, CPRX annual net profit has changed by +$92.48M (+129.50%)

What is Catalyst Pharmaceuticals quarterly net profit?

The current quarterly net income of CPRX is $56.74M

What is the all time high quarterly net income for Catalyst Pharmaceuticals?

Catalyst Pharmaceuticals all-time high quarterly net profit is $56.74M

What is Catalyst Pharmaceuticals quarterly net income year-on-year change?

Over the past year, CPRX quarterly net profit has changed by +$33.46M (+143.77%)

What is Catalyst Pharmaceuticals TTM net profit?

The current TTM net income of CPRX is $197.35M

What is the all time high TTM net income for Catalyst Pharmaceuticals?

Catalyst Pharmaceuticals all-time high TTM net profit is $197.35M

What is Catalyst Pharmaceuticals TTM net income year-on-year change?

Over the past year, CPRX TTM net profit has changed by +$132.23M (+203.07%)
On this page